Drug
lumateperone
Marketed as CAPLYTA.
Generic name
lumateperone
Brand names
CAPLYTA
First FDA approval
2019-12-20
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA209500 | CAPLYTA | 2019-12-20 | INTRA-CELLULAR |
Manufacturers
INTRA-CELLULAR
Frequently asked questions
When was lumateperone FDA approved?
Earliest FDA approval on record: 2019-12-20.
What brand names are sold as lumateperone?
CAPLYTA.
Sources
Appeal a lumateperone denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com